Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy

Published:2020-01 Issue:3 Volume:30 Page:714-724.e5
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

He Bo,Johansson-Percival Anna,Backhouse Joseph,Li Ji,Lee Gabriel Yin Foo,Hamzah Juliana,Ganss Ruth

Funder

National Health and Medical Research Council of Australia

Cancer Council Western Australia

Cancer Research Institute Clinic and Laboratory Integration Program

CLIP

Tour de Cure Senior Research Grant

Woodside Energy Fellowship

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference55 articles.

1. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma;Agemy;Proc. Natl. Acad. Sci. USA,2011

2. Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32;Agemy;Mol. Ther.,2013

3. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation;Allen;Sci. Transl. Med.,2017

4. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma;Amaria;Nat. Med.,2018

5. Evolution of metastases in space and time under immune selection;Angelova;Cell,2018

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth;2024-07-30

3. Milestones in tumor vascularization and its therapeutic targeting;Nature Cancer;2024-06-25

4. An Overview of Cancer Biology, Pathophysiological Development and It’s Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy;Cancer Investigation;2024-06-14

5. Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy;Cancer Research;2024-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3